Argonne and UChicago partner to explore AI in cancer drug discovery
Image credit: cdc via Unsplash
Argonne National Laboratory and the University of Chicago have launched a new partnership to explore how artificial intelligence can support cancer research. The effort focuses on using AI to help screen billions of molecules more quickly, with the goal of identifying potential drug candidates more efficiently. By combining computing tools with biomedical expertise, the collaboration aims to improve the early stages of cancer therapy development.
Source
Archit Vasan, Thomas Brettin, Rick Stevens, Arvind Ramanathan, and Venkatram Vishwanath. 2023. Scalable Lead Prediction with Transformers using HPC resources. In Proceedings of the SC '23 Workshops of the International Conference on High Performance Computing, Network, Storage, and Analysis (SC-W '23). Association for Computing Machinery, New York, NY, USA, 123. https://doi.org/10.1145/3624062.3624081
Additional Reading